Navigation Links
Affymax Reports Phase 2 Clinical Dose Ranging Results of,Once-Per-Month Hematide for the Treatment of Anemia

risks relating to the continued safety and efficacy of Hematide in clinical development, the potential for once per month dosing, regulatory requirements and approvals, research and development efforts, industry and competitive environment, intellectual property rights and disputes and other matters that are described in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement in this press release.

Contact

Affymax, Inc.
Sylvia Wheeler, 650-812-8861
Executive Director, Corporate Communications


'"/>




Page: 1 2 3

Related medicine technology :

1. Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease
2. Affymax Announces Results From Phase 2 Clinical Trial of Hematide for the Treatment of Anemia in Dialysis Patients
3. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
4. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
5. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
8. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine

Post Your Comments:
(Date:11/6/2009)..., WESTBURY, N.Y., Nov. 6 Repo...nd machine tools in the third quarter of 2009 decl...ording to Nassau Asset Management,s NasTrac Quarte...pany,s activity reports for both repossessions and...possessions for both construction and printing equ...
(Date:11/6/2009)..., CHARLESTON, S.C., Nov. 6 /PRNewswire-USNe...l be stopping in South Carolina and Georgia throug...n order to help uninsured and financially-struggli...ovide prescription medicines for free or nearly fr...g 10.2 percent, the Partnership for Prescription A...
(Date:11/6/2009)..., HOPKINTON, Mass., Nov. 6 Fa...quired all of the assets of Archus Orthopedics. Th...ition in product offerings, intellectual property ...vation. "This is a win for patients suffering from...President & CEO, Geoff Pardo. "This consolida...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3Facet Solutions Acquires Archus Orthopedics 2New Quick and Convenient Emergen C 28R 29 Shot Gives Immune Systems a Fighting Chance This Fall 59904 1New Quick and Convenient Emergen C 28R 29 Shot Gives Immune Systems a Fighting Chance This Fall 59904 2New Quick and Convenient Emergen C 28R 29 Shot Gives Immune Systems a Fighting Chance This Fall 59904 3Red Mango to Award Franchises in Atlanta 59900 1Red Mango to Award Franchises in Atlanta 59900 2New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology 5649 1New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology 5649 2New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology 5649 3New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology 5649 4New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology 5649 5New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology 5649 6New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology 5649 7
...tyMetric recognizes MedNet Solutions as the first ... , LINCOLN, R.I., April 7 QualityMetric Incorpor...al life sciences company specializing in clinical ...qualify as a QM Certified Scoring Partner. Quality...program to address a major concern for many in the...
...DELPHIA, April 7 Premier Research Group Limited, ... is pleased to announce that it has submitted an I...ts the 50th IND under management. The milestone IN...a, Analgesia and Rheumatology Products (DAARP), an...of a novel formulation of a non-steroidal anti-inf...
Other Medicine Technology:MedNet Solutions Certified to Score SF-12v2 Health Survey 2MedNet Solutions Certified to Score SF-12v2 Health Survey 3Premier Research Announces Milestone Investigational New Drug Application 2
(Date:11/8/2009)...en Medicare, improve coverage for all Americans ,...SUMMARY: Yesterday the United States House of Rep...gislation that would strengthen Medicare for senio...hat prices millions of Americans out of affordable...re for America Act (H.R. 3962) makes prescription ...
(Date:11/8/2009)...game later, doctors say , , SUNDAY, Nov....of the NFL this season, sidelining such stars as q...ker. , Officials at the American Podiatric Medi...Sports Medicine are warning athletes to take care ...ball and lacrosse. , "Many fall sports athletes...
(Date:11/8/2009)...ons is pleased to announce that it has been succes...eSound who recently received an award on the $800 ... includes not only the Veterans Administration, bu... agencies. , New York, NY...s pleased to announce that it has been successful ...
(Date:11/8/2009)...le is won," said Dr. Charmaine Yoest. ,, WASHI... of 240-194, the Stupak-Ellsworth-Pitts-Kaptur-Dah...ion mandates and funding in HR 3962 passed on the ...n President and CEO Dr. Charmaine Yoest said, "The...o-life Americans across this country who have floo...
(Date:11/8/2009)...swire/ -- The following was released today by Rand...ex. ,, Mr. Terry and his associates from aroun...ling by abortion out of any health care bill for m...rst step to victory -- a touchdown in the first qu.... Our rejoicing must be tempered by reality. The S...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:Rx for Fall Foot Injuries 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2
... study by Miall, Gowen and Tchalenko published by ...www.elsevier.com/locate/cortex ), a brain scanner ...age of the process of drawing faces. The researche...bers key locations and then "joins the dots" with ...
... It" - addresses pressing challenges health care p...mic environments , , MINNEAPOLIS, March 19 Impo... all health care providers related to HIPAA [Healt...ded to the HCCA 13th Annual Compliance Institute c...
...derdale based drug rehabilitation center announced...is month , , FORT LAUDERDALE, Fla., March 19 Th...nounced today that they have served their 691st pa...am, word of mouth from our previous clients and th...
...e seventh consecutive year, Blue Cross and Blue Sh...nc ,s Top 50 Companies for Diversity. BCBSF is ran..., , (Logo: http://www.newscom.com/cgi-bin/prnh/2...loyee resource groups, ranging from military veter...
... of the Company,s Innovative Revenue Cycle Offerin...er for charge capture technologies, today announce...inancing led by existing investor Boston Millennia... of today,s economy require provider organizations...
...edical treatments in the media shows slight improv...th reporting remains poor. , The study of more tha...n media outlets is the most comprehensive investig...ailability of new treatments, the potential harm o...
Other Medicine News:Health News:The brain 'joins the dots' when drawing a cartoon face from memory 2Health News:HIPAA Amendments Contained in President Obama's Stimulus Bill Among New Sessions Added to HCCA's 2009 Compliance Institute 2Health News:HIPAA Amendments Contained in President Obama's Stimulus Bill Among New Sessions Added to HCCA's 2009 Compliance Institute 3Health News:HIPAA Amendments Contained in President Obama's Stimulus Bill Among New Sessions Added to HCCA's 2009 Compliance Institute 4Health News:The Recovery Place Helps Hundreds of Patients Through Drug and Alcohol Rehabilitation 2Health News:Blue Cross and Blue Shield of Florida in DiversityInc's Top 50 Companies for Diversity for Seventh Consecutive Year 2Health News:MedAptus Secures $6 Million Investment 2Health News:Media health reporting: Accuracy improving but still a way to go 2
Soflens66 Toric
Acuvue Toric
Binocular Loupe C 2.3 x 340mm (13in) with Case
Binocular Loupe C 2.3 x 340 K with Case
Medicine Products: